Assessing the Uptake of the Lung Cancer Core Outcome Set: A Cross-Sectional Analysis.

ABSTRACT:

Introduction

A core outcome set (COS) helps standardize outcome measurements across clinical trials. Although lung cancer is the leading cause of cancer-related deaths, research exploring COS implementation across lung cancer trials remains limited. We aim to analyze the uptake of the lung cancer COS and identify potential gaps in COS adherence.

Methods

On June 26, 2023, we conducted a cross-sectional analysis of clinical trials that evaluated lung cancer interventions. Our sample consisted of studies registered on ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform between September 2011 and June 2023. In a masked and duplicate fashion, investigators extracted data regarding trial characteristics and COS adoption. An interrupted time series analys

SUBMITTER: Tran AV 

PROVIDER: S-EPMC11532957 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature